Japan’s leading gene test company which commands about 80 % of the Japanese genetic testing market has decided to switch its microarray supplier from Thermo Fisher to a customized array of Illumina which contains SNPs from over 500.000 people, including East Asians. Genesis Healthcare aims to construct a genetic information database of 1 million people by 2019 and cooperates with IBM Japan.
Genesis Healthcare news release, May 29, 2017
Genesis Healthcare Co. adopts Illumina microarray